BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CASL - Canadian Association for the Study of the Liver - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CASL - Canadian Association for the Study of the Liver
X-ORIGINAL-URL:https://hepatology.ca
X-WR-CALDESC:Events for CASL - Canadian Association for the Study of the Liver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20241128T180000
DTEND;TZID=America/Vancouver:20241128T193000
DTSTAMP:20260423T202152
CREATED:20241004T135938Z
LAST-MODIFIED:20241004T135938Z
UID:4427-1732816800-1732822200@hepatology.ca
SUMMARY:SHINE - Systemic Hepatocellular carcinoma: Incorporating New Emerging therapies
DESCRIPTION:You are cordially invited to SHINE – Systemic Hepatocellular carcinoma: Incorporating New Emerging therapies. A multidisciplinary virtual case-based discussion comprised of leading experts across Western Canada. \nThurs Nov 28 2024\, 6-730 PST | 7-8:30 MST | 8-9:30 CST \n \n  \nPanelists \n\nDr Michael Bleszynski\, HPB Surgeon at Vancouver General Hospital – Vancouver\nDr Mayur Brahmania\, Hepatologist at University of Calgary and CASL’s Education Committee Co-Chair – Calgary\nDr Howard Lim\, Medical Oncologist at BC Cancer Agency – Vancouver\nDr Dave Liu\, Interventional Radiologist at University of British Columbia – Vancouver\nDr Maged Nashed\, Radiation Oncologist at University of Manitoba – Winnipeg\nDr Jennifer Spratlin\, Medical Oncologist at Cross Cancer Institute – Edmonton\nDr Vincent Tam\, Medical Oncologist at Tom Baker Cancer Centre – Calgary\n\nObjectives \n\nUnderstand the current treatment landscape of intermediate HCC.\nAnalyze the emerging role of systemic therapies in TACE/TARE-eligible intermediate HCC.\nDiscuss the use of systemic therapy prior to liver transplant for intermediate stage HCC\npatients.\nExamine future directions and emerging therapies/treatment strategies in intermediate HCC.\n\nPlease RSVP here: https://forms.office.com/e/7qf5GTXZXu
URL:https://hepatology.ca/event/shine-systemic-hepatocellular-carcinoma-incorporating-new-emerging-therapies/
LOCATION:Online
CATEGORIES:Endorsed by CASL,Webinar
END:VEVENT
END:VCALENDAR